Now that Roche has bid for partner Genentech and Bristol-Myers Squibb wants the rest of ImClone, who’s next? The two proposed deals have set off speculation that other biotechs with Big Pharma partners may be the next targets.
There’s Amylin, which partners with Eli Lilly on diabetes shot Byetta as well as other versions like a [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment